Haleon (HLN) Net Income - Minority (2021 - 2022)

Haleon's (HLN) quarterly Net Income - Minority came in at -$33.2 million in Q3 2022, down 124.2% on a QoQ basis from -$14.8 million in Q4 2021.

Haleon (HLN) Net Income - Minority (2021 - 2022) Analysis & Trends

Haleon (HLN) has 2 years of Net Income - Minority data on file, last reported at -$33.2 million in Q3 2022.

Quarterly Net Income - Minority changed N/A year-over-year to -$33.2 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was -$33.2 million (changed N/A YoY) and the FY2021 annual result came in at -$15.1 million, changed N/A from the prior year.
Net Income - Minority fell to -$33.2 million in Q3 2022, from -$14.8 million in the prior quarter.
In the past five years, Net Income - Minority ranged from a high of -$14.8 million in Q4 2021 to a low of -$33.2 million in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Income - Minority (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-	-
2	Teva Pharmaceutical Industries	43.30 Bn	39.65 Bn	2.15 Bn	-
3	Zoetis	31.45 Bn	29.77 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.58 Bn	22.78 Bn	5.10 Bn	-
5	United Therapeutics	22.20 Bn	19.53 Bn	683.80 Mn	-
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.50 Bn	15.11 Bn	935.80 Mn	-
8	Elanco Animal Health	11.70 Bn	11.17 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-	-
10	Alkermes	8.11 Bn	7.46 Bn	397.90 Mn	-

Download Data

Date	Value
Sep 20, 2022	-33.24 Mn
Dec 31, 2021	-14.83 Mn